Literature DB >> 2952187

Quantification of nitrendipine by stable isotope dilution and electron-capture negative ion chemical ionization.

C Fischer, B Heuer, K Heuck, M Eichelbaum.   

Abstract

The electron-capture properties of nitrendipine, a 1,4-dihydro-pyridine derivative with antihypertensive activity, have been applied to develop a sensitive and specific assay in biological fluids using capillary column gas chromatography and measurement in negative ion chemical ionization mode. The synthesis of a 13C4-labelled analogue suitable as a biological internal standard for bioavailability studies and of a 2H8-labelled analogue, which serves as internal standard, is described. The electron-capture positive ion chemical ionization and electron-capture negative ion chemical ionization mass spectra of nitrendipine and its isotope-labelled analogues are compared. The assay has a detection limit of 100 pg ml-1 plasma with a coefficient of variation of 10.2% using the selected ion monitoring mode and electron-capture negative ion chemical ionization. The method is specific, sensitive and accurate to determine terminal half-life times after intravenous and oral administration of nitrendipine and its 13C-analogue. From the nearly identical plasma concentration-time profile of nitrendipine and its 13C-labelled analogue, an isotopic effect can be excluded. Thus, the synthesized 13C4-analogue should be well suited as a biological standard for bioavailability studies.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2952187     DOI: 10.1002/bms.1200131202

Source DB:  PubMed          Journal:  Biomed Environ Mass Spectrom        ISSN: 0887-6134


  5 in total

1.  Lack of effect of nitrendipine on the pharmacokinetics and pharmacodynamics of midazolam during steady state.

Authors:  J Handel; G Ziegler; A Gemeinhardt; H Stuber; C Fischer; U Klotz
Journal:  Br J Clin Pharmacol       Date:  1988-02       Impact factor: 4.335

2.  Pharmacokinetics, bioavailability, metabolism and acute and chronic antihypertensive effects of nitrendipine in patients with chronic renal failure and moderate to severe hypertension.

Authors:  G Mikus; V Mast; C Fischer; C Machleidt; U Kuhlmann; M Eichelbaum
Journal:  Br J Clin Pharmacol       Date:  1991-03       Impact factor: 4.335

3.  Application of stable isotope methodology to study the pharmacokinetics, bioavailability and metabolism of nitrendipine after i.v. and p.o. administration.

Authors:  G Mikus; C Fischer; B Heuer; C Langen; M Eichelbaum
Journal:  Br J Clin Pharmacol       Date:  1987-11       Impact factor: 4.335

4.  Use of pseudoracemic nitrendipine to elucidate the metabolic steps responsible for stereoselective disposition of nitrendipine enantiomers.

Authors:  V Mast; C Fischer; G Mikus; M Eichelbaum
Journal:  Br J Clin Pharmacol       Date:  1992-01       Impact factor: 4.335

5.  Acute haemodynamic effects of i.v. nitrendipine in healthy subjects.

Authors:  G Mikus; C Zekorn; T Brecht; M Eichelbaum
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.